Paul O Mahoney
Registered User
- Messages
- 1,844
Might be due to supply as I said above the deliveries from AZ aren't constant for example 142k were received 2 weeks ago nothing last week and with 90,000 plus administered last week.The second dose of AZ is from anything from eight to twelve weeks. I will be eight weeks on tomorrow Sat. When I rang to find out when I would get my second jab I was told that I was in a queue.
Well I didn't. Because it's UK partner's shares took a huge tumble on the announcement. I felt the pain in my pocket.How did we miss this announcement by Curevac? Its CEO has said that 13 variants weighed on its efficacy which was only 47% out of 40000 trial population. AZ and Pfizer/Biotech are about 90% after 2 doses
I wouldn't be throwing the baby out with the bath water yet. It might be that they got the dosage wrong, I think they encountered flu like side effects at higher dosage and the tweaking was down.Well I didn't. Because it's UK partner's shares took a huge tumble on the announcement. I felt the pain in my pocket.
Was watching Horizon on BBC2 last Tuesday about the development of various vaccines. They spoke to scientists working on the various vaccines. Prof. Teresa Lambe (from Kildare and a UCD graduate) who is one of the co-developers of the AZ vaccine at Oxfords Jenner Institute was very much featured in the programme. Anyway, one of the people involved in the development of the Pfizer MRNA vaccine said that this new technology makes it easier to adapt a vaccine to cope with new variants. That's reassuring news.MRNA technology is still in its infancy and with the virus being with us for an unknown time they might get better results in focusing on specific variants or mix of variants .
I think Prof Lambe got an "honorary knighthood", don't know what the equivalent for a woman is, in the Queens Birthday honours list.Was watching Horizon on BBC2 last Tuesday about the development of various vaccines. They spoke to scientists working on the various vaccines. Prof. Teresa Lambe (from Kildare and a UCD graduate) who is one of the co-developers of the AZ vaccine at Oxfords Jenner Institute was very much featured in the programme. Anyway, one of the people involved in the development of the Pfizer MRNA vaccine said that this new technology makes it easier to adapt a vaccine to cope with new variants. That's reassuring news.
It will be interesting to see how the 4 week interval for AZ works out in terms of side effects, but if it speeds things up go for it.Concerns re: Delta variant have change the equation for risk v benefits for the non mRNA vaccines.
I understand pharmacies are keen to play a bigger role in the vaccination process now that they can use those vaccines on all age groups.
Both the AstraZeneca and Janssen vaccines will be made available for all age groups. They had previously been made available for those over 50.
Earlier today, it emerged that the delay between receiving both doses of the AstraZeneca Covid-19 vaccine is expected to be halved after a recommendation from the National Immunisation Advisory Committee (NIAC).
AstraZeneca and Janssen vaccines to be made available to all age groups
Earlier this month, the gap between doses of this vaccine was reduced from 12 weeks to eight.www.thejournal.ie
AZ maybe not, but I can see J&J being very popular because it is single dose.Will many young people sign up for J&J or AZ given potential side effects in younger people and them being less effective than the Pfizer? I guess the J&J single jab might be attractive to them from an ease of travel and access to indoor hospitality viewpoint. I will advise my older children to wait for the Pfizer.
I like Pfizer delivered just short of 320k doses last week add this to it and we might just get the whole feckin thing done and dusted by All Ireland Final time."Ireland is on the brink of buying one million Covid-19 vaccines from the Romania. I understand the deal includes 700k Pfizer and 300k Moderna doses"
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?